Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-25 @ 2:52 AM
NCT ID:
NCT01182233
Eligibility Criteria:
Inclusion Criteria:
* Age \</= 70 years
* Documented myeloma confirmed at protocol entry
* Adequate presence of \>/=2.0x10e6/kg cryopreserved CD34+ cells
* Adequate organ function
* Prior therapy is allowed as long as the organ function parameters are maintained and/or excessive radiation exposure is not produced
* Chemosensitivity
Exclusion Criteria:
* Uncontrolled infection
* Pregnant or lactating females
* Patients in \>/= very good partial response after initial primary non-transplant therapy and/or AHSCT1
* Patients unwilling to practice adequate forms of contraception if clinically indicated
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01182233
Study Brief:
Protocol Section:
NCT01182233